Acquisition strengthens Obagi Medical’s product portfolio with proven, scientifically backed, injectable portfolio
Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand
Seeking Alpha / 8 hours ago 3 Views
Comments